NASDAQ:FGEN
$16.70
(
-0.89%
)
Friday, 26th May 2023
FibroGen Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $15.89 | $18.15 | Friday, 26th May 2023 FGEN stock ended at $16.70. This is 0.89% less than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 2.89% from a day low at $16.41 to a day high of $16.89. |
| 90 days | $15.89 | $23.53 | |
| 52 weeks | $8.67 | $25.69 |
Historical FibroGen prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $16.67 | $16.89 | $16.41 | $16.70 | 554 559 |
| 2023-05-25 | $16.98 | $17.05 | $16.57 | $16.85 | 625 541 |
| 2023-05-24 | $17.11 | $17.37 | $16.60 | $16.98 | 1 158 706 |
| 2023-05-23 | $17.25 | $18.10 | $17.21 | $17.40 | 773 214 |
| 2023-05-22 | $17.48 | $18.08 | $17.05 | $17.25 | 1 362 804 |
| 2023-05-19 | $17.86 | $18.15 | $17.30 | $17.57 | 698 643 |
| 2023-05-18 | $17.98 | $17.98 | $17.36 | $17.64 | 874 730 |
| 2023-05-17 | $17.50 | $17.94 | $17.36 | $17.82 | 660 699 |
| 2023-05-16 | $17.32 | $17.63 | $17.20 | $17.52 | 452 191 |
| 2023-05-15 | $17.50 | $17.97 | $17.38 | $17.66 | 517 979 |
| 2023-05-12 | $17.52 | $17.76 | $17.17 | $17.43 | 614 367 |
| 2023-05-11 | $17.73 | $18.15 | $17.48 | $17.60 | 560 446 |
| 2023-05-10 | $17.69 | $17.92 | $17.24 | $17.80 | 706 893 |
| 2023-05-09 | $16.75 | $17.94 | $16.24 | $17.42 | 803 534 |
| 2023-05-08 | $17.40 | $17.77 | $17.06 | $17.77 | 867 552 |
| 2023-05-05 | $16.65 | $17.59 | $16.26 | $17.41 | 1 875 834 |
| 2023-05-04 | $16.58 | $16.89 | $16.10 | $16.70 | 584 875 |
| 2023-05-03 | $16.19 | $17.12 | $16.13 | $16.65 | 1 139 405 |
| 2023-05-02 | $16.58 | $16.69 | $15.99 | $16.11 | 944 480 |
| 2023-05-01 | $16.92 | $17.27 | $16.25 | $16.50 | 882 253 |
| 2023-04-28 | $16.59 | $17.38 | $16.56 | $17.12 | 940 880 |
| 2023-04-27 | $16.35 | $16.88 | $16.14 | $16.71 | 909 411 |
| 2023-04-26 | $16.31 | $16.68 | $15.89 | $16.30 | 762 155 |
| 2023-04-25 | $16.84 | $16.98 | $16.21 | $16.39 | 1 693 319 |
| 2023-04-24 | $20.28 | $20.28 | $16.40 | $16.89 | 2 450 181 |
| 2023-04-21 | $20.12 | $20.44 | $19.82 | $20.40 | 748 420 |
| 2023-04-20 | $20.16 | $20.52 | $19.79 | $19.98 | 778 695 |
| 2023-04-19 | $20.12 | $20.73 | $19.88 | $20.40 | 591 092 |
| 2023-04-18 | $20.70 | $20.90 | $20.41 | $20.48 | 694 120 |
| 2023-04-17 | $19.70 | $20.71 | $19.70 | $20.59 | 598 000 |
| 2023-04-14 | $19.61 | $19.68 | $19.30 | $19.63 | 507 915 |
| 2023-04-13 | $18.83 | $20.00 | $18.74 | $19.68 | 843 036 |
| 2023-04-12 | $18.65 | $18.98 | $18.55 | $18.72 | 474 252 |
| 2023-04-11 | $19.17 | $19.33 | $18.45 | $18.51 | 728 375 |
| 2023-04-10 | $19.52 | $19.97 | $18.80 | $19.19 | 648 659 |
| 2023-04-06 | $18.92 | $19.62 | $18.80 | $19.59 | 845 165 |
| 2023-04-05 | $18.70 | $19.08 | $18.52 | $18.85 | 942 079 |
| 2023-04-04 | $18.96 | $19.01 | $18.28 | $18.79 | 662 328 |
| 2023-04-03 | $18.76 | $19.37 | $18.66 | $19.01 | 711 470 |
| 2023-03-31 | $18.83 | $19.07 | $18.45 | $18.66 | 910 763 |
| 2023-03-30 | $19.51 | $19.54 | $18.57 | $18.73 | 775 070 |
| 2023-03-29 | $18.88 | $19.46 | $18.83 | $19.46 | 984 129 |
| 2023-03-28 | $18.64 | $18.96 | $18.64 | $18.81 | 471 636 |
| 2023-03-27 | $18.17 | $18.71 | $18.17 | $18.71 | 500 225 |
| 2023-03-24 | $18.43 | $18.47 | $18.04 | $18.15 | 680 624 |
| 2023-03-23 | $18.71 | $18.94 | $18.20 | $18.67 | 558 662 |
| 2023-03-22 | $19.30 | $19.69 | $18.56 | $18.60 | 932 607 |
| 2023-03-21 | $20.19 | $20.20 | $19.17 | $19.41 | 702 245 |
| 2023-03-20 | $20.10 | $20.10 | $19.72 | $20.00 | 932 051 |
| 2023-03-17 | $20.46 | $20.46 | $19.68 | $20.00 | 1 204 873 |
About FibroGen
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
